Skip to content
Call Us: (+33) 1 64 62 10 12
Theradiag
  • Home
  • Company
    • About us
    • Our history
    • A word from our CEO
    • Our management team
    • Board of directors
    • Know-how
    • Privacy policy
  • Theranostic
    • Therapeutic Drug Monitoring of Biologics – TRACKER
      • Therapeutic Drug Monitoring of Biologics
        • TDM of Biologics
        • When to perform TDM ?
        • Results interpretation
        • Therapeutic Thresholds
        • Tracker Publications
        • Guidelines
        • Frequently asked questions
      • TRACKER
        • LISA TRACKER
        • I-Tracker
        • i-Track 10
        • Immunotrol Tracker
    • Patient Stratification -PredictImmune
    • American Customers
  • Diagnostics
    • Autoimmunity
      • Reagents – Autoimmunity
      • Quality Control – Auto-Immunity
    • SARS-CoV 2 Serology Testing
    • Other fields
    • Instrumentation
      • Theralis
      • Theralis micro
      • FIDIS™
  • Services
    • Technical Documentation Download Center
  • News
    • Press Releases
    • List of upcoming events
    • Congress calendar
  • Investors
    • Welcome Message
    • Financial calendar
    • Financial News
      • Register to receive our latest news
      • Press Releases
      • Financial Reports
      • Financial presentations
    • Shareholder information
      • Stock information
      • Shareholding
      • Analyst coverage
      • Letters to shareholders
      • General meeting
    • Regulated information
      • Share capital and voting rights
      • Corporate governance & internal control
      • Statutory auditors fees
      • Description of the buyback program
      • Prospectus
      • Share buyback statement
      • Charters and code of ethics / Anti-corruption
      • Other regulated information
    • Governance
      • Board of directors
      • Statute and internal regulations
      • Quiet period policy and trading windows
    • Investor contacts and registration
    • Legal notice
  • Contacts
  • Français
  • English
Menu Close

Regulated information

  1. Home>
  2. Investors>
  3. Regulated information

Press Releases

  • 14/01/2021: THERADIAG signs a contract to supply ORGENTEC with quality control reagents called Alegria® Check
  • 11/01/2021: THERADIAG announces CE marking for four new i-Tracker® test kits for biotherapy monitoring
  • 15/12/2020: THERADIAG announces its 2021 financial calendar
  • 14/12/2020: Clinical study that meets French National Authority for Health requirements highlights the quality of the tests marketed by Theradiag
REGISTER FOR OUR LATEST NEWS

Events

18 Mar 2021 - 21 Mar 2021

JFHOD 2021

Palais des Congrès
15 Apr 2021 - 16 Apr 2021

GEAI Colloquium

Institut Pasteur
28 May 2021 - 01 Jun 2021

12th International Congress on Autoimmunity 2020

Megaron Athens International Conference Centre
No event found!
Load More

Next financial Event

No event found!

Useful links

  • Diagnostic
  • Theranostic
  • Events
  • Register to receive our latests news

Contact Information

  • Address:14, Rue Ambroise Croizat, 77183 Croissy Beaubourg, France
  • Phone:+33 1 64 62 10 12
  • Email:info@theradiag.comOpens in your application

Follow Us

Theradiag ©
  • Home
  • Company
    • About us
    • Our history
    • A word from our CEO
    • Our management team
    • Board of directors
    • Know-how
    • Privacy policy
  • Theranostic
    • Therapeutic Drug Monitoring of Biologics – TRACKER
      • Therapeutic Drug Monitoring of Biologics
        • TDM of Biologics
        • When to perform TDM ?
        • Results interpretation
        • Therapeutic Thresholds
        • Tracker Publications
        • Guidelines
        • Frequently asked questions
      • TRACKER
        • LISA TRACKER
        • I-Tracker
        • i-Track 10
        • Immunotrol Tracker
    • Patient Stratification -PredictImmune
    • American Customers
  • Diagnostics
    • Autoimmunity
      • Reagents – Autoimmunity
      • Quality Control – Auto-Immunity
    • SARS-CoV 2 Serology Testing
    • Other fields
    • Instrumentation
      • Theralis
      • Theralis micro
      • FIDIS™
  • Services
    • Technical Documentation Download Center
  • News
    • Press Releases
    • List of upcoming events
    • Congress calendar
  • Investors
    • Welcome Message
    • Financial calendar
    • Financial News
      • Register to receive our latest news
      • Press Releases
      • Financial Reports
      • Financial presentations
    • Shareholder information
      • Stock information
      • Shareholding
      • Analyst coverage
      • Letters to shareholders
      • General meeting
    • Regulated information
      • Share capital and voting rights
      • Corporate governance & internal control
      • Statutory auditors fees
      • Description of the buyback program
      • Prospectus
      • Share buyback statement
      • Charters and code of ethics / Anti-corruption
      • Other regulated information
    • Governance
      • Board of directors
      • Statute and internal regulations
      • Quiet period policy and trading windows
    • Investor contacts and registration
    • Legal notice
  • Contacts
  • Français
  • English
We use cookies to ensure the best experience on our website. If you continue to use this site, we will assume that you are satisfied.OkNoLearn more
Révoquer mon consentementRevoke cookies